HAP Trading’s BioNTech BNTX Stock Holding History

HAP Trading’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,962	Closed	-$1.38M	–	1947
2020 Q4	$1.06M	Buy	+12,962	New	+$1.27M	0.03%	411

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

HAP Trading's BNTX Position: Q1 2021 in Review

HAP Trading sold out of BioNTech (BNTX) in Q1 2021, closing a stake of 12,962 shares — an estimated $1.38M sold.

HAP Trading first reported a position in BNTX in Q4 2020 and held it in 1 quarter. The position peaked at $1.06M in Q4 2020. 225 funds tracked by Wall St. Rank hold BNTX as of Q1 2021.

HAP Trading reported no remaining BioNTech position as of Q1 2021 after selling out during the quarter.
HAP Trading sold 12,962 BioNTech shares in Q1 2021, an estimated $1.38M.
HAP Trading first reported a position in BioNTech in Q4 2020 and held it in 1 quarter.
HAP Trading's BioNTech position peaked at $1.06M in Q4 2020.
225 funds tracked by Wall St. Rank held BioNTech as of Q1 2021.

Based on HAP Trading's 13F filing for Q1 2021, filed 14 May 2021.